Do you want to read an article? Please log in or register.
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
Lung, Respiratory and Thoracic Cancer
